Prevention of catheter-related blood stream infection

Current Opinion in Critical Care

Volumn 13, Issue 4, 2007, Pages 411-415

  Byrnes, Matthew C ^a   Coopersmith, Craig M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteremia; Catheter related blood stream infection; Central venous catheter; Intensive care unit; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTISEPSIS; CATHETER INFECTION; CATHETER REMOVAL; CENTRAL VENOUS CATHETER; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYGIENE; INFECTION PREVENTION; MEDICAL EDUCATION; PROPHYLAXIS; REVIEW; SEPSIS;

BLOOD; CATHETERIZATION; HUMANS; INFECTION CONTROL; UNITED STATES;

EID: 34347358724     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0b013e3281f8d279     Document Type: Review

References (53)

1. Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004; 32:2014-2020.
2. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-2732. This landmark study evaluated the effect of a comprehensive program to prevent CR-BSIs in 103 ICUs in Michigan. The authors demonstrate a simple intervention decreases infection rates 66% statewide with sustained follow-up.
3. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
4. Mermel LA, Eggimann P, Harbarth S, et al. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402.
5. O'Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51:1-29.
6. Warren DK, Quadir WW, Hollenbeak CS, et al. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a non-teaching hospital. Crit Care Med 2006; 34:2084-2089. This well performed study examined the cost and length of stay associated with CR-BSI in a medical/surgical ICU. Unlike many studies on CR-BSI, which look at academic medical centers, this examines these parameters in a suburban, non-teaching hospital.
7. Dimick JB, Pelz RK, Consunji R, et al. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg 2001; 136:229-234.
8. Higuera F, Rosenthal VD, Duarte P, et al. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med 2005;33:2022-2027.
9. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control 2003; 31:291-295.
10. Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 2005; 41:1591-1598.
11. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-981.
12. Diekema DJ, Beekmann SE, Chapin KC, et al. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol 2003; 41:3655-3660.
13. Albert RK, Condie F. Hand-washing patterns in medical intensive-care units. N Engl J Med 1981; 304:1465-1466.
14. Jenner EA, Fletcher BC, Watson P, et al. Discrepancy between self-reported and observed hand hygiene behaviour in healthcare professionals. J Hosp Infect 2006; 63:418-422. This study examined the discrepancy between what healthcare workers report and what is observed regarding hand hygiene. Seventy-one healthcare professionals were observed for 132h and over 1000 hand hygiene opportunities. The authors found that observed hand hygienewas unrelated to either healthcare worker intention or self-reporting.
15. Maury E, Alzieu M, Baudel JL, et al. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit. Am J Respir Crit Care Med 2000; 162:324-327.
16. Goldmann D. System failure versus personal accountability-the case for clean hands. N Engl J Med 2006; 355:121-123. This opinion piece eloquently argues for personal responsibility in hand hygiene.
17. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338:339-343.
18. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med 2002; 136:792-801.
19. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5%tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis 2000; 31:1001-1007.
20. Chaiyakunapruk N, Veenstra DL, Lipsky BA. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 2003; 37:764-771.
21. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:1-8.
22. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91:197S-205S.
23. Hu KK, Veenstra DL, Lipsky BA, Saint S. Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes. Clin Infect Dis 2004; 39:1441-1445.
24. Lorente L, Henry C, Martin MM, et al. Central venous catheter-related infection in a prospective and observational study of 2,595 catheters. Crit Care 2005; 9:R631-R635.
25. Nagashima G, Kikuchi T, Tsuyuzaki H. To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization? J Infect Chemother 2006; 12:363-365. This single-center study examined CR-BSI in subclavian, internal jugular and femoral routes. Examining all patients, CR-BSI rates were 3.8/1000 catheter days for subclavian CVCs, 6.1/1000 catheter days for internal jugular CVCs and 15.7 for femoral CVCs. In ICU patients, CR-BSI rates were twice as high when placed in the internal jugular as compared with the subclavian vein.
26. Charalambous C, Swoboda SM, Dick J. Risk factors and clinical impact of central line infections in the surgical intensive care unit. Arch Surg 1998; 133:1241-1246.
27. Ruesch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access-a systematic review. Crit Care Med 2002; 30:454-460.
28. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001; 286:700-707.
29. Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281:261-267.
30. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobialimpregnated central venous catheters. Catheter Study Group. N Engl J Med 1999; 340:1-8.
31. Brun-Buisson C, Doyon F, Sollet JP, et al. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial. Intensive Care Med 2004; 30: 837-843.
32. Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med 2005; 143:570-580.
33. Moretti EW, Ofstead CL, Kristy RM, Wetzler HP. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 2005; 61:139-145.
34. Corral L, Nolla-Salas M, Ibanez-Nolla J, et al. A prospective, randomized study in critically ill patients using the Oligon Vantex catheter. J Hosp Infect 2003; 55:212-219.
35. Bong JJ, Kite P, Wilco MH, McMahon MJ. Prevention of catheter related bloodstream infection by silver iontophoretic central venous catheters: a randomised controlled trial. J Clin Pathol 2003; 56:731-735.
36. Ranucci M, Isgro G, Giomarelli PP, et al. Impact of oligon central venous catheters on catheter colonization and catheter-related bloodstream infection. Crit Care Med 2003; 31:52-59.
37. Fraenkel D, Rickard C, Thomas P, et al. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters. Crit Care Med 2006; 34:668-675. This single center prospective, randomized trial compared minocycline/rifampin and silver/platinum/carbon CVCs on CR-BSI rate and colonization. In 574 CVCs examined, CR-BSI rates were similar (1.4 and 1.7% respectively), but colonization rates were lower with the minocycline/rifampin catheters (8.4 versus 14.6%).
38. Crnich CJ, Maki DG. Are antimicrobial-impregnated catheters effective? When does repetition reach the point of exhaustion? Clin Infect Dis 2005; 41:681-685.
39. McConnell SA, Gubbins PO, Anaissie EJ. Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection? Clin Infect Dis 2003; 37:65-72.
40. Schuerer DJE, Zack JE, Thomas J, et al. The effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an ICU with low bloodstream infection rates following implementation of a successful educational program: a before-after trial. Surgical Infections (in press).
41. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med 1994; 22:1729-1737.
42. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother 2006; 58:281-287. This meta-analysis of eight studies demonstrated decreased CVC colonization and a nonsignificant trend toward decreased CR-BSI using chlorhexidine-impregnated dressings. Based upon these results, the authors recommend a large prospective randomized trial to evaluate the efficacy of these dressings.
43. Eyer S, Brummitt C, Crossley K, et al. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med 1990; 18:1073-1079.
44. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med 1992; 327:1062-1068.
45. Cook D, Randolph A, Kernerman P, et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 1997; 25:1417-1424.
46. Gillies D, O'Riordan L, Wallen M, et al. Optimal timing for intravenous administration set replacement. Cochrane Database Syst Rev 2005; CD003588.
47. Niel-Weise BS, Daha TJ, van den Broek PJ. Is there evidence for recommending needleless closed catheter access systems in guidelines? A systematic review of randomized controlled trials. J Hosp Infect 2006; 62:406-413. This is a well done review of five randomized trials of needleless closed catheter access systems. The authors conclude the quality of the trials was 'generally unsatisfactory' and while there is no infection risk that would warrant not using these systems, convincing evidence does not exist to warrant recommending them.
48. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol 1985; 121:182-205.
49. Coopersmith CM, Rebmann TL, Zack JE, et al. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med 2002; 30:59-64.
50. Coopersmith CM, Zack JE, Ward MR, et al. The impact of bedside behavior on catheter-related bacteremia in the intensive care unit. Arch Surg 2004; 139:131-136.
51. Sherertz RJ, Ely EW, Westbrook DM, et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Lancet 2000; 132:641-648.
52. Eggimann P, Harbarth S, Constantin MN, et al. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 2000; 355:1864-1868.
53. Frankel HL, Crede WB, Topal JE, et al. Use of corporate Six Sigma performance-improvement strategies to reduce incidence of catheter-related bloodstream infections in a surgical ICU. J Am Coll Surg 2005; 201:349-358.